885268-47-3 Usage
Uses
Used in Pharmaceutical Drug Synthesis:
Tert-butyl 1,7-diazaspiro[4,4]nonane-1-carboxylate is used as a building block in the synthesis of various pharmaceutical drugs and organic compounds. Its unique spiro structure and stability contribute to the development of new and effective medications.
Used in Organic Synthesis:
In the field of organic synthesis, Tert-butyl 1,7-diazaspiro[4,4]nonane-1-carboxylate serves as a valuable reagent. Its non-reactivity under normal conditions allows for its use in a wide range of chemical reactions, facilitating the creation of diverse organic compounds.
Used in Medicinal Chemistry and Drug Discovery:
Due to its unique spiro structure and potential biological activity, Tert-butyl 1,7-diazaspiro[4,4]nonane-1-carboxylate may have applications in the field of medicinal chemistry and drug discovery. Researchers can explore its properties and interactions to identify new therapeutic agents and advance drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 885268-47-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,2,6 and 8 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 885268-47:
(8*8)+(7*8)+(6*5)+(5*2)+(4*6)+(3*8)+(2*4)+(1*7)=223
223 % 10 = 3
So 885268-47-3 is a valid CAS Registry Number.
InChI:InChI=1/C12H22N2O2/c1-11(2,3)16-10(15)14-8-4-5-12(14)6-7-13-9-12/h13H,4-9H2,1-3H3
885268-47-3Relevant academic research and scientific papers
Preparation and characterization of N-(3-pyridinyl) spirocyclic diamines as ligands for nicotinic acetylcholine receptors
Sippy, Kevin B.,Anderson, David J.,Bunnelle, William H.,Hutchins, Charles W.,Schrimpf, Michael R.
scheme or table, p. 1682 - 1685 (2009/11/30)
Several N-pyridin-3-yl spirobicyclic diamines, designed as conformationally restricted analogs of tebanicline (ABT-594), were synthesized as novel ligands for nicotinic acetylcholine receptors (nAChR). The spirocyclic compounds exhibited weaker binding affinity, than other constrained analogs in accord with a pharmacophore model. Nevertheless, some (1a, 1b) possessed (partial) agonist potencies comparable to nicotine at the α4β2 subtype, but with greatly improved selectivity relative to the α3β4* nAChR.
Practical synthesis of structurally important spirodiamine templates
Tang,Qu,Xu,Ma,Chen, Shu-Hui,Li
, p. 3793 - 3799 (2008/02/10)
A general, concise, four-step synthetic sequence for the preparation of spirodiamine templates is described herein. Copyright Taylor & Francis Group, LLC.
